Search Results - "LEFEBVRE, Patricia"

Prevalence, Molecular Epidemiology, and Clinical Significance of Heterogeneous Glycopeptide-Intermediate Staphylococcus aureus in Liver Transplant Recipients by BERT, Frédéric, CLARISSOU, Juliette, DURAND, Francois, DELEFOSSE, Didier, CHAUVET, Chantal, LEFEBVRE, Patricia, LAMBERT, Nicole, BRANGER, Catherine

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Phase I Pharmacokinetic, Food Effect, and Pharmacogenetic Study of Oral Irinotecan Given as Semisolid Matrix Capsules in Patients with Solid Tumors by SOEPENBERG, Otto, DUMEZ, Herlinde, LEFEBVRE, Patricia, ASSADOURIAN, Sylvie, SANDERINK, Ger-Jan, SPARREBOOM, Alex, VAN OOSTEROM, Allan T, VERWEIJ, Jaap, DE JONG, Floris A, DE JONGE, Maja J. A, THOMAS, José, ESKENS, Ferry A. L. M, VAN SCHAIK, Ron H. N, SELLESLACH, Johan, TER STEEG, Judith

“…Purpose: To characterize the maximum-tolerated dose, recommended dose, dose-limiting toxicities (DLT), pharmacokinetic profile, and food effect of orally…”
Get full text

Single- and Multiple-Dose Pharmacokinetics of Riluzole in White Subjects by Liboux, Aimé Le, Lefebvre, Patricia, Roux, Yvonne Le, Truffinet, Philippe, Aubeneau, Michel, Kirkesseli, Stéphane, Montay, Guy

“…Riluzole is a novel neuroprotective agent that has been developed for the treatment of amyotrophic lateral sclerosis. A series of studies was undertaken to…”
Get full text

Accuracy and generalizability of using automated methods for identifying adverse events from electronic health record data: a validation study protocol by Rochefort, Christian M, Buckeridge, David L, Tanguay, Andréanne, Biron, Alain, D'Aragon, Frédérick, Wang, Shengrui, Gallix, Benoit, Valiquette, Louis, Audet, Li-Anne, Lee, Todd C, Jayaraman, Dev, Petrucci, Bruno, Lefebvre, Patricia

“…Adverse events (AEs) in acute care hospitals are frequent and associated with significant morbidity, mortality, and costs. Measuring AEs is necessary for…”
Get full text

Phase I study of an oral formulation of irinotecan administered daily for 14 days every 3 weeks in patients with advanced solid tumours by SCHOEMAKER, Nadja E, KUPPENS, I. E. L. M, TEN BOKKEL HUININK, Wim W, LEFEBVRE, Patricia, BEIJNEN, Jos H, ASSADOURIAN, Sylvie, SANDERINK, Ger-Jan, SCHELLENS, Jan H. M

“…A phase I study was conducted with oral irinotecan given daily for 14 days every 3 weeks in 45 patients with solid tumours to establish the maximum tolerated…”
Get full text

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer by BHARGAVA, Pankaj, MARSHALL, John L, RIZVI, Naiyer A, FRIED, Karen, WILLIAMS, Marion, LEFEBVRE, Patricia, DAHUT, William, HANFELT, John, GEHAN, Edmund, FIGUERA, Manuela, HAWKINS, Michael J

“…To determine the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and effect of drug sequence on toxicities and pharmacokinetics of the combination…”
Get full text

Enhancement of O6-methylguanine-DNA-methyltransferase activity induced by various treatments in mammalian cells by LEFEBVRE, P, LAVAL, F

“…The O6-methylguanine-DNA-methyltransferase (methyltransferase) activity was determined in a rat hepatoma cell line after treatment with ultraviolet or…”
Get full text

A human cell line proficient in O6-methylguanine-DNA-methyltransferase and hypersensitive to alkylating agents by Lefebvre, P, Laval, F

“…The involvement of O6-methylguanine (O6-meGua) in mutagenesis is well established, while the toxic effect of these residues is still controversial. In this…”
Get more information

Hospitals report on medication safety in Canada by Greenall, Julie, Lefebvre, Patricia, Hyland, Sylvia, Salsman, Bonnie

“…Measurement of safety can be difficult. Given that incident reporting systems rely primarily on voluntary reporting and some types of medication incidents may…”
Get more information

Potentiation of N-methyl-N'-nitro-N-nitrosoguanidine-induced O6-methylguanine-DNA-methyltransferase activity in a rat hepatoma cell line by poly (ADP-ribose) synthesis inhibitors by Lefebvre, P, Laval, F

“…The O6-methylguanine-DNA-methyltransferase (transferase) activity in a rat hepatoma cell line (H4 cells) is enhanced as a response to DNA damaging agents. To…”
Get more information

On-chip microfluidics for proteomic analysis by electrospray ionization/mass spectrometry by Tabourier, P., Druon, C., Rolando, C., Lefebvre, P.

“…Describes the development of a silicon integrated demonstrator coupled to an ElectroSpray Ionization source in view of protein analysis by Mass Spectrometry…”
Get full text